GENEVA, Oct. 5 -- SOLGATE GMBH filed a patent application (EP2026/058805) for “NEW HETEROCYCLIC COMPOUNDS REDUCING THE TASL PROTEIN LEVEL”. With publication no. WO/2026/202277, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 401/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....